Ellenbarrie Q1 FY27: PAT +87% YoY, but core segment profit up a more modest 21%
PAT +86.8% YoY · revenue +18% · margins expanding
₹98.72 Cr
+18% YoY
₹34.96 Cr
+86.8% YoY
30.2%
+9.5pp YoY
₹2.48
Ellenbarrie Industrial Gases' standalone Q1 FY27 (quarter ended 30 June 2026) revenue rose 18.0% YoY to ₹98.72 Cr (₹87.43 Cr QoQ, +12.9%), while PAT jumped 86.8% YoY to ₹34.96 Cr (₹22.88 Cr in Q4 FY26, +52.8% QoQ) and EPS rose to ₹2.48 from ₹1.42 a year ago. No consensus estimate for this specific quarter turned up in public brokerage previews — Motilal Oswal's most recent published estimate revisions were annual FY27 EPS upgrades (~6%) rather than a quarterly PAT call — so vsStreet is unknown rather than a formal beat or miss.
Q1 FY-2027 vs prior quarters
The headline PAT growth outpaces the underlying business: total segment operating profit (Gases + Project Engineering, before finance costs and other income) rose a more moderate 20.6% YoY to ₹37.01 Cr, in line with the 20.3% YoY growth in the core Gases segment. The gap between that and the 86.8% PAT jump comes from two balance-sheet-driven swings — finance costs fell 57.6% YoY to ₹1.95 Cr after the company used ₹210 Cr of IPO proceeds to fully prepay outstanding borrowings, and other income rose 149.8% YoY to ₹17.06 Cr, largely treasury interest earned on the ₹58.18 Cr of IPO proceeds still parked in fixed deposits/monitoring accounts as of 30 June 2026. NPM (PAT/total income) expanded to 30.2% from 20.7% YoY and 22.4% QoQ, and EBITDA margin (PBT + finance cost + depreciation − other income, over revenue) improved to ~38.1% from 36.7% YoY and 31.1% QoQ, closing in on — but still short of — management's 40% medium-term EBITDA margin aspiration from the Q4 FY26 call.
The stock went into the print at ₹292.35, up 9.3% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 5 quarters; revenue is at a 5-quarter high.
Management expresses confidence in achieving a 20% revenue CAGR over the next 2-3 years, driven by the commissioning and ramp-up of new merchant and on-site capacities. They target a medium-term EBITDA margin aspiration of 40%, supported by improved power efficiency, potential argon price recovery, and operating levera
— This quarter: met
Against the 20% revenue CAGR management guided for over 2-3 years on the back of new merchant and on-site capacity, this quarter's 18.0% YoY growth is broadly on track though a touch below pace; the margin trajectory likewise supports management's confidence without yet confirming the 40% target. No separate management press release accompanied this filing beyond the standard board-outcome letter; the company has scheduled its Q1 FY27 earnings call for August 10, 2026. Alongside the results, the board approved a slate of governance appointments — internal auditors (A.R. Maiti & Co.), cost auditors (Datta, Ghosh, Bhattacharya & Associates) and a new Chief Information Officer (Sujoy Sen, ex-Linde) — none numbers-moving but reflecting continued post-IPO institutional build-out.
W1
Uluberia-II ASU (220 TPD) commissioning — ₹42.14 Cr of the ₹104.50 Cr earmarked remains unutilised as of Jun-26; watch progress toward the 20% revenue CAGR management guided from new capacity.
W2
EBITDA margin trending toward management's 40% medium-term aspiration (38.1% this quarter vs 36.7% YoY) — watch whether power efficiency and argon price recovery close the remaining ~2pp gap.
W3
Treasury/other income (₹17.06 Cr this quarter) should taper as the remaining ₹58.18 Cr of unutilised IPO proceeds is deployed into capex — watch the resulting mix shift back toward core operating profit.
18% Growth Delivered, but 40% Margin Target Moves to 'Longer-Term'
Strong revenue growth (+18% YoY) and exceptional PAT growth (+87% YoY) track toward multi-year targets, but EBITDA margin came in at 39%—90 basis points shy of the 40% aspiration management just reframed as a longer-term goal, not a quarterly guarantee.
₹98.7 Cr
+18% YoY vs Q1 FY26 ₹83.6 Cr
₹38.7 Cr
+21% YoY at 39.1% margin
₹35.0 Cr
+87% YoY vs Q1 FY26 ₹18.7 Cr
39.1%
90 bps miss; reframed as longer-term aspiration
The quarter in plain language
Ellenbarrie delivered a solid quarter: revenue of ₹98.7 crore (up 18% year-on-year) and profit of ₹35.0 crore (up 87% year-on-year) are both strong and in line with the company's multi-year narrative of capacity-led growth. The quarter benefits from two merchant plants—Kurnool and Uluberia 2—ramping utilization through FY27, and core gases revenue (oxygen, nitrogen, argon) grew 20% year-on-year to ₹97.3 crore. Operationally, that's the bull case: disciplined execution on new capacity and expanding the asset footprint into North India and West Central India, with an on-site pipeline management describes as 'very robust' (multiple inquiries above 600 TPD, some exceeding 1,000 TPD).
But the earnings note sits on one uncomfortable gap: EBITDA margin delivered 39.1%, versus the 40% aspiration management has articulated. That's a 90-basis-point miss. On the call, management attributed this to argon pricing volatility and Q4 one-offs, then explicitly reframed the 40% target as a 'longer-term aspiration,' not a quarterly guarantee—a semantic hedge that tells you the near-term path to 40% is neither obvious nor certain.
The margin miss: claims vs. what holds up
Q1 revenue ₹98.7 Cr, 18% YoY growth
Delivered 98.7 Cr; Q1 FY26 was 83.6 Cr; growth confirmed at 18%
Supported
PAT 35.0 Cr, 87% YoY growth
Delivered 35.0 Cr; Q1 FY26 was 18.7 Cr; growth confirmed at 87%
Supported
Targeting 40% EBITDA margins or higher long-term
Q1 delivered 39.1%; 90 bps below target; management reframed as longer-term, not quarterly
Overstated as near-term
Argon prices recovered modestly since Q3 lows; still below H1 FY26
Management confirmed current prices lower than H1 FY26, above 200-day MA, mid-range of long-term trend
Supported
Growth driven by Kurnool and Uluberia 2 ramp-up
Core gases revenue +20% YoY to ₹97.3 Cr; timing and scale align with plant commissioning
Supported
Disciplined cost control supporting margins despite capacity expansion
Margin at 39% vs. 40% aspiration suggests limited margin expansion from cost control alone
Partial
What changed on this call
Three material shifts from prior guidance:
Capex roadmap advanced to active construction. North India (~220 TPD) and West Central (~230 TPD) merchant plants are now under construction, with ₹250 crore budgeted for FY27 and ₹200 crore for FY28. Prior calls outlined these; this call moves them from planning into execution.
Argon pricing narrative shifted. From prior calls' upside visibility, to this call's explicit hedging: volatile, below H1 FY26 levels, but structurally upward over a 3–4 year cycle. Management downplayed argon's benefit to Q1 margins despite analyst pressure.
On-site inquiry pipeline upgraded. Multiple inquiries for 600+ TPD plants (some 1,000+ TPD) are now active; East India 320-TPD plant (Jay Balaji customer) confirmed live Q2 FY27. Visibility improved from prior calls.
40% margin target reframed as longer-term aspiration. No guidance lowered, but management explicitly clarified the target is not a quarterly guarantee—a post-hoc hedge that maps to the 90-bps miss.
The bull-bear ledger
Revenue growth (18% YoY) is on track toward the 20% CAGR aspiration
PAT growth (87% YoY) demonstrates strong operating leverage as new capacity ramps
Core gases segment expanded 20% YoY to ₹97.3 Cr; margin stable at 38% despite new capacity
Two merchant plants (Kurnool, Uluberia 2) ramping on schedule; East India on-site live Q2
On-site pipeline 'very robust' with multiple large inquiries (600+ TPD); diversified end-markets (steel ~33%, non-steel ~67%)
Capex roadmap now in active construction phase; ₹250 Cr FY27 + ₹200 Cr FY28 firmed for North/West plants
EBITDA margin 39% vs. 40% aspiration (90 bps miss) suggests new capacity efficiency gains are being offset by argon pricing headwinds
Argon prices remain below H1 FY26 levels; any further weakness would pressurize margins near-term
Management reframed 40% margin target as longer-term, clarifying it's not a quarterly guarantee—a post-hoc hedge
Macro uncertainty acknowledged ('requires caution'); power costs variable; renewable PPAs still under negotiation
New merchant plant ramps assume 18–24 months to 80–90% utilization; execution delays or weaker-than-expected uptake would pressure revenue trajectory
On-site order pipeline is 'active' but no binding orders disclosed; conversion risk remains
Risks, ranked by how much they should concern a holder
Argon pricing volatility and margin sustainability
MediumQ1 margin of 39% missed the 40% target. Argon prices are structurally upward but currently below H1 FY26 levels; quarterly swings of 20–30% are possible. If argon prices dip further, the path to 40% margins without price tailwinds is unclear. Management's post-hoc reframing suggests near-term confidence is limited.
Merchant plant ramp-up execution and utilization risk
MediumKurnool and Uluberia 2 assume 18–24 months to 80–90% utilization. Delays or lower-than-expected demand uptake would pressure the revenue trajectory toward the 20% CAGR target. North/West plants under construction face similar execution risk.
On-site order pipeline conversion risk
MediumMultiple inquiries (600+ TPD, some 1,000+ TPD) are described as 'very robust,' but no binding orders have been disclosed. Conversion timeline and terms are uncertain. East India plant (Jay Balaji) live Q2 FY27 demonstrates progress, but pipeline remains inquiry-stage.
Power cost inflation and renewable PPA delays
Low-to-MediumOne renewable PPA signed; more under negotiation. If commodity power prices spike or PPA negotiations stall, power cost (a primary input) could pressurize margins. Management's focus on cost discipline depends on PPA execution.
Macro uncertainty and uneven demand
Low-to-MediumManagement explicitly noted macro environment 'requires caution.' Geopolitical uncertainty, currency fluctuations, and uneven demand across end-user industries (steel, chemicals, pharma) could slow adoption of new capacity in North/West regions.
How the street is positioned
The post-result price action tells a nuanced story. The day-1 pop of +1.15% was subdued, suggesting initial caution on the margin miss. But by day 3, the stock had rallied +10.76% from the pre-result close—a move that reflects the market repricing for growth momentum and new capacity catalysts. The key point: the pop held. The stock closed the day-3 window above the result-announcement close, implying the market's initial skepticism gave way to conviction on the narrative.
But the current positioning carries warnings. The stock trades at ₹323.8 (as of 2026-08-12), sitting 31.62% below its all-time high but up 85% from the 52-week low—a strong recovery from the trough that has now extended into overbought territory. RSI stands at 71, suggesting retail and momentum buyers have chased the pop hard. Volume trend is increasing, which typically flags extended positions vulnerable to profit-taking on the next headline.
More concerning: institutional positioning has shifted. FII ownership declined to 1.08% (from 1.31% in Q4), and DII also trimmed slightly to 11.62% (from 13.02%). This suggests that even as retail chases the post-result bounce, larger institutions are cautiously stepping back—a divergence that historically precedes pullbacks when growth doesn't immediately translate to margin expansion. Promoter holding is steady at 77.15%, offering no signal of insider concern or confidence.
Read together: the street has priced in the growth narrative and capacity ramps, and rewarded the stock accordingly. But the margin miss, the argon hedge, and the FII trim suggest institutions are waiting for Q2 to see whether management can defend or recover toward the 40% target. The overbought RSI and increasing volume make the Q2 quarter-end a pivot point—if margins slip further or argon prices dip, the post-result pop could fade quickly.
The debate
What to watch next
1 · Q2 EBITDA margin delivery
The critical read. East India plant (Jay Balaji, 320 TPD) goes live Q2, adding on-site revenue. If Q2 margin recovers toward 40% (or above) as new capacity contribution kicks in, the bear case weakens. If margin stays at 39% or dips below, the question shifts to 'when will argon recover and/or when will new capacity leverage show?'
2 · Argon pricing recovery to H1 FY26 levels
Management tied 40% margins to structural demand recovery and efficient new capacity, but implicitly hedged on price. If argon prices rise materially by Q2/Q3, margins would likely respond. This is the single most sensitive variable to the margin debate.
3 · On-site order announcements and North/West merchant plant construction milestones
The pipeline is 'active' but unbooked. Any new on-site orders (particularly large ones >600 TPD) or substantive updates on North India and West Central merchant plant construction progress would validate the growth narrative and reduce execution risk. Lack of progress would signal slower-than-expected demand conversion.
The single number to track
From here, watch EBITDA margin quarterly. Q1's 39% against a 40% aspiration sets the bar. If Q2 crosses 40% or edges toward it, the margin narrative stabilizes and the long-term 20% revenue CAGR becomes more credible. If Q2 stalls at 39% or dips, argon pricing and new capacity efficiency become the material concerns, and the stock's current overbought RSI and FII trim will likely trigger a pullback.
Ellenbarrie's story is neither a bull breakout nor a bear trap—it's a steady growth narrative (18% revenue growth is real, PAT leverage is real) running into a structural margin question (argon pricing and new capacity leverage are real but uncertain near-term). The post-result pop reflects fair pricing for the growth; the institutional trim reflects warranted caution on margins. Q2 will tell whether management's 40% aspiration is a multi-year slow walk or a near-term recovery. Until then: Hold.
Strong revenue growth, margin miss vs. aspiration
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Delivered on prior revenue growth trajectory (18% vs 20% CAGR aspiration); margin guidance reaffirmed but not met this quarter (39% vs 40% target).
Optimistic
next 1–2 quarters
Optimistic
multi-year
Ellenbarrie delivered strong revenue growth (18% YoY) and exceptional PAT growth (87% YoY) driven by Kurnool and Uluberia 2 ramps, but EBITDA margin came in at 39% versus 40% long-term aspiration—a 90bps miss that management attributes to argon pricing volatility and one-off Q4 items rather than underlying weakness. Key risk: argon prices remain structurally below H1 FY26 levels and management hedges the 40% margin as a multi-year target, not a quarterly guarantee.
₹98.7 Cr
Revenue · +18% YoY₹35 Cr
Reported PAT · +86.8% YoYFlat
Margins · vs guidance: MixedDid the claims hold up?
Q1 FY27 revenue 987 million, 18% YoY growth
METDelivered 98.7 Cr (987M), confirms 18% YoY vs Q1 FY26 83.6 Cr
PAT 350 million, 87% YoY growth
METDelivered 35.0 Cr (350M), confirms 86.8% YoY growth (87% rounded)
EBITDA margin 39%, targeting 40% or higher long-term
OVERSTATEDDelivered OPM 38.1%, EBITDA 38.7 Cr at 39.1% margin vs 40% aspiration = 90bps miss
Argon prices recovered modestly since Q3 FY26 lows, still below H1 FY26
METMgmt confirmed current prices lower than H1 FY26 levels, above 200-day DMA, in middle of long-term trend
Growth primarily driven by Kurnool and Uluberia 2 ramp-up
METCore gases revenue 97.3 Cr (+20% YoY), margin 38%, but cause-and-effect not quantified in results
Disciplined cost control supporting margins despite capacity expansion
PartialPower efficiency gains from new plants and renewable PPA claimed, but 39% margin vs 40% aspiration suggests limited margin expansion
Earnings quality
What changed since the last call
Margin guidance reaffirmed
NeutralManagement explicitly reiterated 40%+ EBITDA margin as longer-term aspiration (not raised), but clarified not a quarterly guarantee; quarter delivered 39%.
Argon pricing narrative shifted
DowngradeFrom prior call's upside visibility, to this call's 'volatile, below H1 FY26 but structurally upward' with 3–4 year cycle; hedging on impact.
Capex roadmap firmed
UpgradeNorth + West Central merchant plants now under construction (₹250 Cr FY27, ₹200 Cr FY28); prior calls outlined, now in execution.
On-site inquiry pipeline upgrade
UpgradeMultiple inquiries above 600 TPD (some for 1000+ TPD) now active; Jay Balaji East India plant confirmed live Q2; broader than prior visibility.
The Q&A
Analysts (Vatsal, Bhavika, Jay) pressed hard on margin sustainability given argon volatility and whether 40% target is achievable without price tailwinds. Management held firm on long-term guidance but pragmatically hedged quarterly variability. No significant pushback on capacity expansion or execution; analysts largely satisfied with operational discipline and ramp trajectory.
North India merchant plant customer demand — Vatsal Bhandari, Singularity AMC
AnsweredNo advance contracts; survey target customers 1–3 months pre-commissioning; assume 18–24 month ramp to 80–90% utilization; focus on greenfield demand growth in region.
Argon pricing impact on margins — Vatsal Bhandari, Singularity AMC
PartialQ4 had one-offs; structurally, argon prices have upward 10-year trend; expect 40%+ margins as capacity expands, not price-dependent; acknowledge quarterly volatility.
Argon pricing and margin consistency — Bhavika Singhvi, Niveshaay
PartialArgon had limited impact Q1; main driver is new efficient capacity and cost control; long-term demand-supply in favor of manufacturers; accepting quarterly volatility; targeting 40%+ longer-term, not quarterly.
Capex deployment across plants — Bhavika Singhvi, Niveshaay
AnsweredNorth India merchant (not operational yet) and West Central merchant plants; combined ~450–500 TPD; construction underway.
Argon pricing recovery magnitude — Jay Pawar, Nuvama PCG
PartialNo specific percentage; Q3 was low point; recovered in H2 FY26 and further Q1; current prices still below H1 FY26 but above 200-day DMA; in middle of long-term uptrend.
West merchant plant product mix (ASU vs. specialty gases) — Jay Pawar, Nuvama PCG
AnsweredWest plant is ASU merchant (liquefied O2, N2, Ar); evaluating specialty gas add-on but not confirmed; lower margin than ASU manufacturing.
Solar cell electronic gases opportunity — Vatsal Bhandari, Singularity AMC
AnsweredElectronic gases mostly imported, warehoused, supplied; lower EBITDA margin (trading business) vs. ASU manufacturing; investment in containers, debulking, safety required but lower than ASU.
Merchant ASU payback period — Vatsal Bhandari, Singularity AMC
AnsweredTypically 18 months build + 18–24 months ramp + 3 years payback = ~5 years to stable cash generation.
On-site vs. merchant revenue split long-term — Arpit Jain, Wallfort Financial Services
PartialHard to target; merchant under management control, on-site contract-driven; Q1 on-site ₹14 Cr (~20% revenue), bulk ₹70 Cr (~80%), but on-site capacity higher; seek balanced growth.
Large on-site plant pipeline (1000+ TPD) — Arpit Jain, Wallfort Financial Services
AnsweredLarge plants only on-site; multiple inquiries above 600 TPD active; will execute if won; largest plant will be contract-determined.
East India on-site plant timeline — Bhavika Singhvi, Niveshaay
AnsweredUnder commissioning; revenue expected Q2 FY27.
Jay Balaji follow-on orders — Bhavika Singhvi, Niveshaay
AnsweredUnlikely; customers typically use one ASU for longer-term capacity; on-site order pipeline (steel + non-steel) remains very strong; multiple inquiries active.
Customer concentration and sector diversity — Bhavika Singhvi, Niveshaay
AnsweredSteel largest single industry (~33% revenue), but non-steel is ~67%; active across chemicals, pharma, engineering, defense, solar; diversified.
Guidance
FY27 focus on execution, utilization, margin discipline; no FY27 revenue target stated
HighNear-term drivers: East India on-site Q2, Uluberia 2 utilization, Kurnool ramp; North India merchant plant (220 TPD) construction ongoing for FY27–28.
20% revenue CAGR aspiration (prior guidance, reaffirmed by delivery of 18% YoY Q1)
MediumContingent on new merchant plant ramps (450–500 TPD North + West combined) and on-site inquiry pipeline execution; inquiry volume 'very robust.'
40% or higher EBITDA margin long-term aspiration
MediumReaffirmed this call; clarified as longer-term target, not quarterly guarantee. Q1 delivered 39% (90bps miss). Management attributes to argon pricing volatility and one-off Q4 items, not structural.
Margin protection via newer energy-efficient plants, higher production, cost rationalization, renewable energy savings
MediumRenewable PPA signed; more under negotiation. Depends on power commodity prices, argon pricing recovery, and execution on cost levers.
₹250 Cr FY27, ₹200 Cr FY28 capex
HighAllocated to North India (~220 TPD) and West Central (~230 TPD) merchant plants under construction. Phased deployment through FY27–28.
Growth investments in capacity with strong customer visibility, attractive returns, long-term strategic value
MediumBalanced merchant/on-site mix; on-site inquiries (multiple, 600+ TPD) being evaluated; merchant locations deepening pan-India presence.
Risks the call surfaced
Argon pricing volatility
MediumArgon prices below H1 FY26 levels; quarterly swings 20–30% possible; margins highly sensitive. Structural uptrend supports long-term but near-term volatility real.
Macro uncertainty & power costs
MediumMacro environment 'requires caution'; geopolitical uncertainty, energy price movement, currency fluctuations noted. Power is key input; cost management dependent on renewable PPAs and commodity prices.
New plant ramp-up execution
MediumKurnool and Uluberia 2 ramping; assume 18–24 month to 80–90% utilization. Delays or lower-than-expected uptake would pressure revenue and margin trajectory.
On-site order pipeline conversion
MediumMultiple on-site inquiries (600+, some 1000+ TPD) active; described as 'very strong' but no committed orders disclosed. Conversion risk and timeline uncertain.
Merchant plant competition in new regions
LowNorth India and West Central India merchant plants entering competitive markets with existing suppliers. No advance contracts; rely on greenfield demand and location advantage.
Management
Score 7/10. Professional, measured, disciplined. Management explicit on macro caution and hedging on margin guidance (40% reframed as 'longer-term target'). Transparent on argon pricing volatility and power cost as key variables. Withheld specific unit economics (plant-level payback only disclosed as aggregate company level). High on operational detail, lower on forward specifics. Track record strong: Q1 delivered 18% revenue growth (toward 20% CAGR), 87% PAT growth. Two merchant plants (Kurnool, Uluberia 2) ramping on plan. East India on-site plant moving into commissioning (Jay Balaji customer, 320 TPD). New plants described as more power-efficient, supporting margin thesis. One renewable PPA signed; more under negotiation. Cost control noted but 39% EBITDA margin fell short of 40% target.
1 · Q2 FY27
East India 320 TPD on-site plant (Jay Balaji customer) goes live
2 · H2 FY27
North India merchant plant (~220 TPD) and West Central (~230 TPD) construction ramp
3 · Ongoing FY27
Kurnool and Uluberia 2 merchant plants ramp capacity utilization toward 80–90% sweet spot
Key risk: argon prices remain structurally below H1 FY26 levels and management hedges the 40% margin as a multi-year target, not a quarterly guarantee.